Description
Tirzepatide is a synthetic peptide that acts as a dual agonist of the GIP and GLP-1 receptors, which has made it a frequent reference compound in metabolic, endocrine, and incretin-pathway research. This presentation is a lyophilized powder in a vial, for reconstitution in the laboratory.
Tirzepatide Specifications
- Classification: Synthetic dual GIP/GLP-1 receptor agonist peptide (39 amino acids, C-terminal amide)
- Compound: Tirzepatide (synthetic GIP / GLP-1 dual receptor agonist peptide)
- Receptors: GIP and GLP-1 (dual incretin agonist)
- Sequence: Y-Aib-E-G-T-F-T-S-D-Y-S-I-Aib-L-D-K-I-A-Q-K(AEEA-AEEA-γGlu-C20 diacid)-A-F-V-Q-W-L-I-A-G-G-P-S-S-G-A-P-P-P-S-NH2
- Molecular formula: C225H348N48O68
- Molecular weight: 4813.5 g/mol
- CAS number: 2023788-19-2
- Format: White to off-white lyophilized powder, supplied in a vial; 20 mg per vial
- Solubility: Reconstitute with bacteriostatic water
- Storage: Store lyophilized at -20 °C, desiccated and protected from light
Research focus
Tirzepatide is studied across energy-homeostasis and body-weight regulation models, glucose-regulation research, and incretin-receptor pharmacology.
For laboratory reconstitution, pair with our bacteriostatic water.
For laboratory research use only. Not for human or veterinary use; not for consumption.







